[Federal Register Volume 59, Number 145 (Friday, July 29, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-18465]
[[Page Unknown]]
[Federal Register: July 29, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health; Statement of Organization,
Functions, and Delegations of Authority
Part H, Chapter HN (National Institutes of Health) of the Statement
of Organization, Functions, and Delegations of Authority for the
Department of Health and Human Services (40 FR 22859, May 27, 1975, as
amended most recently at 59 FR 35128, July 8, 1994) is amended to
reflect the establishment of the Office of Policy Analysis and
Technology Transfer (HNM16) and the Office of Research on Minority and
Women's Health (HNM18) within the Office of the Director, National
Institute of Allergy and Infectious Diseases (HNM1).
Section HN-B, Organization and Functions is amended as indicated:
(1) Under the heading National Institute of Allergy and Infectious
Diseases (HNM), Office of the Director (HNM1), insert the following:
Office of Policy Analysis and Technology Transfer (HNM16). (1)
Provides support and serves as liaison to program managers in
coordinating, integrating, and articulating long-range program goals
and strategies; (2) is responsible for the development and coordination
of the Institute's annual Planning and Reporting process; (3) maintains
a continuing liaison with program planning counterparts in other ICDs
and in the OD/NIH; (4) advises Institute Task Forces to assure that the
charge and work of the Task Forces are directed toward the projected
planning and evaluation needs of the Institute; (5) conducts the intra-
institute program assignments of all research, training, career and
fellowship grant applications; (6) analyzes, interprets, and classifies
the scientific content of research grants, contracts, and intramural
research projects, and manages the scientific information data and
coding of the Multi-Axis Coding System (MACS); (7) directs and
coordinates all program evaluation activities, assessing the impact and
focus of programs which are of major concern to the Institute; (8)
advises on material for Congressional budget presentations; (9) directs
and coordinates the legislative liaison, legislative tracking and
analysis for the Institute; (10) manages the Executive Secretariat
(controlled correspondence) functions for the Institute; (11) fosters,
supports, and implements technology development and transfer to ensure
that Congressional mandates outlined in the Federal Technology Transfer
Act of 1986 are established, implemented, and monitored; and (12)
serves as the focus for communications for trans-NIH concerns.
Office of Research on Minority and Women's Health (HNM18). (1)
Provides the Director, NIAID and senior staff with advice and guidance
on matters relating to research on minority and women's health and
enhanced minority and women's participation in research; (2) serves as
the NIAID focal point for establishing NIAID-wide goals for minority
and women's research and training programs and for the coordination and
development of these programs; (3) develops and implements a trans-
NIAID plan to improve research on minority populations and women on
diseases and conditions that affect minority and women
disproportionately; (4) creates initiatives to enhance the research
efforts targeted to minority and women's health, increase the
effectiveness of outreach and education programs, and develop the
research infrastructure at minority institutions; (5) informs the
scientific and medical communities and other Government agencies of
NIAID minority and women's health activities and involves them in
efforts to expand and encourage minority and women's health research
and training programs; and (6) assists the Director, NIAID in reviewing
and assessing the Institute's activities with respect to clinical
trials involving minorities and women, and collaborates with the
Institute's Division Directors and other senior medical staff on the
conception, design, development, and implementation of clinical trials
which are either exclusively focused on, or include, minorities and
women.
Dated: July 18, 1994.
Harold Varmus,
Director, NIH.
[FR Doc. 94-18465 Filed 7-28-94; 8:45 am]
BILLING CODE 4140-01-M
